OMDA

Handel nachbörslich: 23.28 -0.73 -3.04%

Omada Health Inc (OMDA)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Omada Health Inc Stock (OMDA) Company Profile

Omada Health Inc

Healthcare (1141)

888-987-8337

500 SANSOME STREET, SAN FRANCISCO

Nächster Verdiensttermin

Neueste SEC-Einreichungen

OMDA's Discussions on Twitter

Vergleichen Sie OMDA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OMDA Omada Health Inc	24.01	1.40B	0	0	0	0.00
VEEV Veeva Systems Inc	286.59	48.92B	2.97B	809.93M	1.33B	4.8743
TEM Tempus Ai Inc	96.39	17.25B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	65.61	13.59B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	90.52	7.99B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	35.70	7.14B	906.14M	-52.62M	89.62M	-0.3621

Omada Health Inc Stock (OMDA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-05	Eingeleitet	Robert W. Baird	Neutral
2025-07-01	Eingeleitet	Barclays	Overweight
2025-07-01	Eingeleitet	Canaccord Genuity	Buy
2025-07-01	Eingeleitet	Evercore ISI	Outperform
2025-07-01	Eingeleitet	Goldman	Buy
2025-07-01	Eingeleitet	JP Morgan	Overweight
2025-07-01	Eingeleitet	Morgan Stanley	Overweight
2025-07-01	Eingeleitet	Needham	Buy

Alle ansehen

Omada Health Inc Aktie (OMDA) Neueste Nachrichten

Finanzdaten der Omada Health Inc-Aktie (OMDA)

Es liegen keine Finanzdaten für Omada Health Inc (OMDA) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Omada Health Inc (OMDA)

Omada Health Inc Stock (OMDA) Company Profile

Vergleichen Sie OMDA mit anderen Aktien

Omada Health Inc Stock (OMDA) Upgrades & Downgrades

Omada Health Inc Aktie (OMDA) Neueste Nachrichten

Omada Health's (OMDA) Sell (D) Rating Reaffirmed at Weiss Ratings - MarketBeat

Omada Health’s Digital Care Bet Outpaces Wall Street Expectations - Finimize

Omada Health, Inc. (NASDAQ:OMDA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Omada Health (NASDAQ:OMDA) Trading Up 7.6%Time to Buy? - MarketBeat

United States Digital Therapeutics Market Trends & Forecast | - openPR.com

Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients - HIT Consultant

Omada Health Launches 'Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie Counting - The Manila Times

Beyond Calorie Counting: Omada Health's New AI Meal Map Revolutionizes Digital Nutrition Guidance - Stock Titan

Omada Health, Inc. (NASDAQ:OMDA) Receives $24.50 Consensus PT from Analysts - MarketBeat

Omada Health: Multiple Indicators Convince Me The Growth Outlook Remains Healthy - Seeking Alpha

Omada Health (NASDAQ:OMDA) Stock Price Down 5.9%Here's What Happened - MarketBeat

Omada Health (NASDAQ:OMDA) Upgraded to Hold at Baird R W - MarketBeat

Omada simplifies and accelerates IGA deployment while lowering total cost of ownership - Yahoo Finance

United States 7MM Digital Therapeutics for Diabetes Market - openPR.com

How Does Omada Health Stack Up After a 26% Share Price Surge? - Yahoo Finance

New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions - Yahoo Finance

Just 0.8% Weight Change: Omada Health's Groundbreaking Study Challenges Post-GLP-1 Weight Regain Assumptions - Stock Titan

Omada Health Develops Threat Model to Assess AI Risks in Healthcare - geneonline.com

Omada Health, Inc.(NasdaqGS: OMDA) added to NASDAQ Composite Index - MarketScreener

Baird initiates coverage on Omada Health stock with Neutral rating By Investing.com - Investing.com Australia

Omada Health shares fall 2.23% intraday after Baird initiates coverage with a Neutral rating and $24 price target. - AInvest

Baird Initiates Omada Health at Neutral With $24 Price Target - MarketScreener

Baird initiates coverage on Omada Health stock with Neutral rating - Investing.com

Baird Initiates Omada Health(OMDA.US) With Hold Rating, Announces Target Price $24 - 富途牛牛

Heartflow, Inc. shares rise 2.21% premarket after new research from Omada Health demonstrates lower healthcare utilization and spending for patients using virtual physical therapy programs. - AInvest

Omada Health announce research on cost savings of virtual physical therapy - TipRanks

Omada Health Study Shows Virtual PT Saves on Medical Care and Costs. - AInvest

Omada Health Study Finds Virtual Physical Therapy Saves Significant Costs for Musculoskeletal Conditions - AInvest

New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy - Yahoo Finance

$1,000+ Per Patient: Omada's Virtual Physical Therapy Outperforms Traditional Care in Major Cost Study - Stock Titan

Omada Health shares fall 1.75% premarket ahead of senior management's participation in Morgan Stanley's Global Healthcare Conference. - AInvest

Heartflow, Inc. shares rise 2.87% premarket after Omada Health's senior management participation in Morgan Stanley's Global Healthcare Conference. - AInvest

Omada Health shares rise 3.31% intraday after announcing participation in Morgan Stanley's Global Healthcare Conference. - AInvest

Omada Health to Participate in Upcoming Investor Conference - Yahoo Finance

Virtual Healthcare Leader Omada Health to Present at Morgan Stanley's 23rd Global Healthcare Conference - Stock Titan

Omada Health, Inc. (NASDAQ:OMDA) Receives $24.57 Average PT from Brokerages - MarketBeat

Healthcare Analysts Bullish on CSL, UnitedHealth, and Omada Health - AInvest

Omada Health stock rises on market debut - MSN

U.S. Digital Therapeutics Market Positioned for Accelerated - openPR.com

Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare

Visana Health Appoints Chief Commercial Officer to Drive New Growth - Business Wire

Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Gilead Sciences (GILD) and Cytokinetics (CYTK) - The Globe and Mail

Omada Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating - TipRanks

Omada grows revenue, membership in public earnings debut - Healthcare Dive

Omada Health 2025 Q2 Earnings Losses Narrow Sharply, 50% Year-Over-Year Reduction in Net Loss - AInvest

Omada Health revenue jumps 49% year-over-year post-IPO - TechTarget

Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 By Investing.com - Investing.com South Africa

Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 - Investing.com Nigeria

Barclays raises Omada Health PT to $24, maintains Overweight rating. - AInvest

Freedom Broker lowers Omada Health stock price target to $20 from $26 - Investing.com India

Freedom Broker lowers Omada Health stock price target to $20 from $26 By Investing.com - Investing.com South Africa

Finanzdaten der Omada Health Inc-Aktie (OMDA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie OMDA